283 related articles for article (PubMed ID: 7378311)
1. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
Edgar W; Warrell MJ; Warrell DA; Prentice CR
Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
[TBL] [Abstract][Full Text] [Related]
2. Proceedings: Haemostatic changes following snake bite by Echis carinatus; trial of heparin.
Prentice CR; Warrell DA; Forbes CD; Edgar W
Thromb Diath Haemorrh; 1975 Sep; 34(1):350-1. PubMed ID: 1188797
[No Abstract] [Full Text] [Related]
3. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo.
Woodhams BJ; Than T; Than T; Hutton RA
Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816
[TBL] [Abstract][Full Text] [Related]
4. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria.
Warrell DA; Davidson NMcD ; Greenwood BM; Ormerod LD; Pope HM; Watkins BJ; Prentice CR
Q J Med; 1977 Jan; 46(181):33-62. PubMed ID: 866568
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
[TBL] [Abstract][Full Text] [Related]
6. [Defibrination syndrome after snake bites].
Meissner A; Hausmann B; Linn C; Piepgras P; Mönig H; Wronski R; Bruhn HD
Dtsch Med Wochenschr; 1989 Sep; 114(39):1484-7. PubMed ID: 2477208
[TBL] [Abstract][Full Text] [Related]
7. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
Pfitzner SA; Dempfle CE; Matsuda M; Heene DL
Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
[TBL] [Abstract][Full Text] [Related]
8. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
[TBL] [Abstract][Full Text] [Related]
9. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
Smith EB
Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
[TBL] [Abstract][Full Text] [Related]
10. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
Connaghan DG; Francis CW; Lane DA; Marder VJ
Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
[TBL] [Abstract][Full Text] [Related]
11. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
[TBL] [Abstract][Full Text] [Related]
12. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
Lane DA; Preston FE; VanRoss ME; Kakkar VV
Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
[TBL] [Abstract][Full Text] [Related]
13. Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms.
Warrell DA; Davidson NM; Omerod LD; Pope HM; Watkins BJ; Greenwood BM; Ried HA
Br Med J; 1974 Nov; 4(5942):437-40. PubMed ID: 4154124
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction.
Sørensen JV; Jensen HP; Rahr HB; Borris LC; Lassen MR; Fedders O; Haase JP; Knudsen F
Haemostasis; 1993; 23(2):91-7. PubMed ID: 8365691
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
16. Plasma thrombin assay using a chromogenic substrate in disseminated intravascular coagulation due to snake bite envenomation.
Herrmann RP; Bailey PE
Thromb Haemost; 1979 May; 41(3):544-52. PubMed ID: 462421
[TBL] [Abstract][Full Text] [Related]
17. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
[TBL] [Abstract][Full Text] [Related]
18. Plasmic degradation of fibrinogen Paris I.
Budzynski AZ; Marder VJ
J Lab Clin Med; 1976 Nov; 88(5):817-25. PubMed ID: 978044
[TBL] [Abstract][Full Text] [Related]
19. The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests.
Brenner B; Francis CW; Marder VJ
J Lab Clin Med; 1989 Jun; 113(6):682-8. PubMed ID: 2732616
[TBL] [Abstract][Full Text] [Related]
20. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
